PT971585E - Compostos tetraciclina no tratamento de certos tipos de cancros - Google Patents
Compostos tetraciclina no tratamento de certos tipos de cancrosInfo
- Publication number
- PT971585E PT971585E PT98902437T PT98902437T PT971585E PT 971585 E PT971585 E PT 971585E PT 98902437 T PT98902437 T PT 98902437T PT 98902437 T PT98902437 T PT 98902437T PT 971585 E PT971585 E PT 971585E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- cells
- growth
- tetracycline compounds
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- -1 TETRACYCLINE COMPOUNDS Chemical class 0.000 title abstract 2
- 239000004098 Tetracycline Substances 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 229960002180 tetracycline Drugs 0.000 title abstract 2
- 229930101283 tetracycline Natural products 0.000 title abstract 2
- 235000019364 tetracycline Nutrition 0.000 title abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 2
- 230000005907 cancer growth Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000009401 metastasis Effects 0.000 abstract 2
- NBRQRXRBIHVLGI-OWXODZSWSA-N (4as,5ar,12ar)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=CC=CC(O)=C2C(O)=C(C2=O)[C@@H]1C[C@@H]1[C@@]2(O)C(O)=C(C(=O)N)C(=O)C1 NBRQRXRBIHVLGI-OWXODZSWSA-N 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/783,655 US5837696A (en) | 1997-01-15 | 1997-01-15 | Method of inhibiting cancer growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT971585E true PT971585E (pt) | 2006-08-31 |
Family
ID=25130005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98902437T PT971585E (pt) | 1997-01-15 | 1998-01-15 | Compostos tetraciclina no tratamento de certos tipos de cancros |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5837696A (enExample) |
| EP (1) | EP0971585B1 (enExample) |
| JP (1) | JP4428727B2 (enExample) |
| KR (1) | KR20000070212A (enExample) |
| AT (1) | ATE321452T1 (enExample) |
| AU (1) | AU729886B2 (enExample) |
| CA (1) | CA2277865C (enExample) |
| DE (1) | DE69834024T2 (enExample) |
| ES (1) | ES2262221T3 (enExample) |
| PT (1) | PT971585E (enExample) |
| WO (1) | WO1998031224A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837696A (en) * | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
| US6429204B1 (en) | 1997-01-15 | 2002-08-06 | University Of Miami | Method of inhibiting cancer growth |
| DK1041991T3 (da) * | 1997-12-19 | 2008-07-28 | Univ New York | Ikke-antibakterielle tetracycliner til behandling af multipel sklerose |
| US6277061B1 (en) * | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
| US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
| US5977091A (en) * | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| CA2356462A1 (en) * | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6984619B1 (en) * | 1999-03-19 | 2006-01-10 | Arch Development Corporation | Method for protection against tumor metastasis formation |
| DE10032256C2 (de) * | 2000-07-03 | 2003-06-05 | Infineon Technologies Ag | Chip-ID-Register-Anordnung |
| US20040115261A1 (en) * | 2001-04-05 | 2004-06-17 | Ashley Robert A. | Controlled delivery of tetracycline compounds and tetracycline derivatives |
| US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
| EP2332547A1 (en) | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of inflammatory bowel disease |
| EP1439843A4 (en) * | 2001-10-05 | 2007-01-03 | Tetragenex Pharmaceuticals Inc | TETRACYCLINE DERIVATIVES AND METHODS OF USE |
| PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| EP2311796A1 (en) | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| WO2003075857A2 (en) | 2002-03-08 | 2003-09-18 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
| EA200401232A1 (ru) | 2002-03-21 | 2005-12-29 | Пэрэтек Фамэсьютикэлс, Инк. | Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта |
| EP1501490A2 (en) * | 2002-05-06 | 2005-02-02 | Collagenex Pharmaceuticals, Inc. | Methods of simultaneously treating mucositis and fungal infection |
| US20050164993A1 (en) * | 2002-05-20 | 2005-07-28 | Ashley Robert A. | Methods of treating allergic reactions |
| KR101089429B1 (ko) | 2002-07-12 | 2011-12-07 | 파라테크 파마슈티컬스, 인크. | 3, 10, 및 12ａ 치환된 테트라시클린 화합물 |
| EP1562608A4 (en) * | 2002-10-24 | 2010-09-01 | Paratek Pharm Innc | METHOD OF USE OF SUBSTITUTED TETRACYCLINE COMPOUNDS FOR MODULATING THE RNA |
| WO2004091483A2 (en) | 2003-04-07 | 2004-10-28 | Shire Laboratories, Inc. | Once daily formulations of tetracyclines |
| KR101228706B1 (ko) | 2003-07-09 | 2013-02-01 | 파라테크 파마슈티컬스, 인크. | 치환된 테트라시클린 화합물 |
| EP1656341A1 (en) | 2003-07-09 | 2006-05-17 | Paratek Pharmaceuticals, Inc. | Prodrugs of 9-aminomethyl tetracycline compounds |
| EP1716101A1 (en) * | 2004-01-15 | 2006-11-02 | Paratek Pharmaceuticals, Inc. | Aromatic a-ring derivatives of tetracycline compounds |
| CA2585418A1 (en) | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
| EP2269978A3 (en) | 2004-10-25 | 2011-09-21 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| CA2616224A1 (en) * | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
| EP3045449A1 (en) | 2006-12-21 | 2016-07-20 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| CA2673486C (en) * | 2006-12-21 | 2015-09-08 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| WO2008134048A2 (en) * | 2007-04-27 | 2008-11-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| EA201070048A1 (ru) * | 2007-07-06 | 2010-10-29 | Паратек Фармасьютикалс, Инк. | Способы синтеза замещённых соединений тетрациклина (варианты) |
| TWI585071B (zh) | 2008-05-19 | 2017-06-01 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| PL3000805T3 (pl) | 2008-08-08 | 2018-04-30 | Tetraphase Pharmaceuticals, Inc. | C7-fluoro podstawione związki tetracyklinowe |
| ES2627772T3 (es) | 2009-05-08 | 2017-07-31 | Tetraphase Pharmaceuticals, Inc. | Compuestos de tetraciclina |
| WO2011025982A2 (en) | 2009-08-28 | 2011-03-03 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| EP2544692A4 (en) * | 2010-03-10 | 2013-08-07 | Univ Health Network | USE OF TIGECYCLIN FOR THE TREATMENT OF CANCER |
| ES2621409T3 (es) | 2010-03-31 | 2017-07-04 | Tetraphase Pharmaceuticals, Inc. | Compuestos policíclicos de tetraciclina |
| AU2013308504B2 (en) | 2012-08-31 | 2016-11-10 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| EP2943193A2 (en) * | 2013-01-14 | 2015-11-18 | Health Clinics Limited | Cancer drug and uses |
| KR102880712B1 (ko) | 2016-10-19 | 2025-11-03 | 테트라페이즈 파마슈티컬스, 인코포레이티드 | 에라바사이클린의 결정질 형태 |
| EP3612177A4 (en) | 2017-04-21 | 2021-01-13 | Lunella Biotech, Inc. | TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY |
| WO2018195434A1 (en) | 2017-04-21 | 2018-10-25 | Lisanti Michael P | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
| CA3063717C (en) | 2017-05-19 | 2021-08-24 | Lunella Biotech, Inc. | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| EP3624897A4 (en) | 2017-05-19 | 2021-07-14 | Lunella Biotech, Inc. | COMPANION DIAGNOSIS FOR MITOCHONDRIAL INHIBITORS |
| WO2020097450A1 (en) | 2018-11-09 | 2020-05-14 | Tetraphase Pharmaceuticals, Inc. | Polymorphic forms of a compound and uses thereof |
| CN115006411A (zh) * | 2022-07-26 | 2022-09-06 | 中南大学湘雅医院 | 依拉环素类化合物的应用、药物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3016587B2 (ja) * | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
| US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| WO1992012717A2 (en) * | 1991-01-15 | 1992-08-06 | A composition containing a tetracycline and use for inhibiting angiogenesis | |
| US5668122A (en) * | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
| US5563130A (en) * | 1994-12-13 | 1996-10-08 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
| US5567693A (en) * | 1994-12-13 | 1996-10-22 | American Cyanamid Company | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
| US5574026A (en) * | 1994-12-13 | 1996-11-12 | American Cyanamid Company | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth |
| US5837696A (en) * | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
-
1997
- 1997-01-15 US US08/783,655 patent/US5837696A/en not_active Expired - Lifetime
-
1998
- 1998-01-15 JP JP53443498A patent/JP4428727B2/ja not_active Expired - Fee Related
- 1998-01-15 KR KR1019997006438A patent/KR20000070212A/ko not_active Ceased
- 1998-01-15 PT PT98902437T patent/PT971585E/pt unknown
- 1998-01-15 AU AU59104/98A patent/AU729886B2/en not_active Ceased
- 1998-01-15 CA CA002277865A patent/CA2277865C/en not_active Expired - Fee Related
- 1998-01-15 ES ES98902437T patent/ES2262221T3/es not_active Expired - Lifetime
- 1998-01-15 DE DE69834024T patent/DE69834024T2/de not_active Expired - Lifetime
- 1998-01-15 WO PCT/US1998/000332 patent/WO1998031224A1/en not_active Ceased
- 1998-01-15 EP EP98902437A patent/EP0971585B1/en not_active Expired - Lifetime
- 1998-01-15 AT AT98902437T patent/ATE321452T1/de active
- 1998-01-15 US US09/007,645 patent/US6100248A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0971585A1 (en) | 2000-01-19 |
| US5837696A (en) | 1998-11-17 |
| WO1998031224A1 (en) | 1998-07-23 |
| EP0971585B1 (en) | 2006-03-29 |
| CA2277865C (en) | 2009-06-02 |
| AU729886B2 (en) | 2001-02-15 |
| EP0971585A4 (en) | 2001-01-24 |
| JP2001508794A (ja) | 2001-07-03 |
| KR20000070212A (ko) | 2000-11-25 |
| DE69834024T2 (de) | 2006-12-07 |
| JP4428727B2 (ja) | 2010-03-10 |
| ATE321452T1 (de) | 2006-04-15 |
| CA2277865A1 (en) | 1998-07-23 |
| DE69834024D1 (de) | 2006-05-18 |
| AU5910498A (en) | 1998-08-07 |
| ES2262221T3 (es) | 2006-11-16 |
| US6100248A (en) | 2000-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT971585E (pt) | Compostos tetraciclina no tratamento de certos tipos de cancros | |
| MX9804009A (es) | Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8. | |
| DK1019060T3 (da) | Androgensynteseinhibitorer | |
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| YU596A (sh) | Estrogen agonisti/antagonisti | |
| DE60040981D1 (de) | BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN | |
| DK1214292T3 (da) | Tyrosinderivater | |
| DK0768885T3 (da) | Fremgangsmåde til inhibering af cancermetastase ved oral administration af oplöselig modificeret citruspectin | |
| ZA988826B (en) | Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation | |
| IL147017A0 (en) | TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES | |
| MY122020A (en) | Use of gabab receptor agonists as reflux inhibitors | |
| MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
| TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
| BR9912327A (pt) | Inibidores da uroquinase | |
| TR200002921T2 (tr) | Yarı-Sentetik ekteinasidinler | |
| HUP0104688A2 (hu) | Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez | |
| BR0008788A (pt) | Sequencias anti-sentido antitumor dirigidas contra componentes r1 e r2 de ribonucleotìdeo reductase | |
| DE69902523D1 (de) | Verwendung von erythropoietin zur behandlung von multiple myelom | |
| TR199800243T1 (xx) | Prolil endopeptidaz inhibit�rleri. | |
| MXPA02007173A (es) | Compuestos calciliticos. | |
| IL189502A0 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
| EP1383511A4 (en) | CALCILYTIC COMPOUNDS | |
| IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds | |
| CA2294243A1 (en) | Novel cyanoaziridines for treating cancer | |
| ATE480237T1 (de) | Tumorhemmende nitroacridin-zusammensetzungen |